Latest Breaking News On - பியர் லெவில் - Page 1 : comparemela.com
Deep-South Receives DTC Eligibility in the US
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
NA Proactive news snapshot: Water Tower Research, Gevo Inc, American Manganese Inc, DGTL Holdings Inc, Phunware Inc, Gevo Inc , CytoDyn Inc, TPCO Holding Corp, Esports Entertainment Group Inc, Beyond Medical Technologies Inc
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.
CEO Presenting on the Emerging Growth Conference on May 26 Register here
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.
NA Proactive news snapshot: Mydecine Innovations Group Inc, Aion Therapeutic Inc, EVmo Inc, Alpine 4 Holdings Inc, Dalrada Corporation , Ayurcann Holdings Corp, HempFusion Wellness Inc, Fireweed Zinc Ltd, Fury Gold Mines Ltd, Ridgeline Minerals Corp, AIM
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.
A glance at some of the day s highlights from the Proactive Investors US and Canada newswires Your daily round-up from the world of Proactive
Mydecine Innovations Group Inc (NEO:MYCO) (OTCMKTS:MYCOF) (FRA:0NFA) announced that it ended the first quarter of 2021 with cash and equivalents of C$11.3 million, which the company said will help it advance its intellectual property portfolio, build out its clinical trial calendar, expand its European operations and develop its technology division. As well, Mydecine said its strategic partnerships are expected to expand its drug development capabilities to more efficiently and rapidly lead the next generation of psychedelic-assisted therapeutics.